COMT and anxiety and cognition in children with chromosome 22q11.2 deletion syndrome

Psychiatry Research

Volumn 178, Issue 2, 2010, Pages 433-436

  Shashi, Vandana ^a,b   Howard, Timothy D ^b   Keshavan, Matcheri S ^c   Kaczorowski, Jessica ^c   Berry, Margaret N ^b   Schoch, Kelly ^a   Spence, Edward J ^e   Kwapil, Thomas R ^d  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^e CAROLINAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE;

ADOLESCENT; ALLELE; ANXIETY DISORDER; ARTICLE; BRAIN FUNCTION; CHILD; CHROMOSOME 22Q; CHROMOSOME DELETION; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; DIGEORGE SYNDROME; DISEASE ASSOCIATION; FEMALE; HUMAN; INFORMATION PROCESSING; INTELLIGENCE QUOTIENT; MALE; MENTAL DISEASE; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ANXIETY; CATECHOL O-METHYLTRANSFERASE; CHILD; COGNITION DISORDERS; DIGEORGE SYNDROME; EXECUTIVE FUNCTION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METHIONINE; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; VALINE;

EID: 77953869270     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2010.04.048     Document Type: Article

References (52)

1. Achenbach T.M., Ruffle T.M. The Child Behavior Checklist and related forms for assessing behavioral/emotional problems and competencies. Pediatric Reviews 2000, 21:265-271.
2. APA Diagnostic and Statistical Manual of Mental Disorders (DSM) 2000.
3. Baker K.D., Skuse D.H. Adolescents and young adults with 22q11 deletion syndrome: psychopathology in an at-risk group. British Journal of Psychiatry 2005, 186:115-120.
4. Baker K., Baldeweg T., Sivagnanasundaram S., Scambler P., Skuse D. COMT Val108/158 Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome. Biological Psychiatry 2005, 58:23-31.
5. Barnett J.H., Heron J., Goldman D., Jones P.B., Xu K. Effects of catechol-O-methyltransferase on normal variation in the cognitive function of children. American Journal of Psychiatry 2009, 166:909-916.
6. Bassett A.S., Caluseriu O., Weksberg R., Young D.A., Chow E.W. Catechol-O-methyl transferase and expression of schizophrenia in 73 adults with 22q11 deletion syndrome. Biological Psychiatry 2007, 61:1135-1140.
7. Bearden C.E., Jawad A.F., Lynch D.R., Sokol S., Kanes S.J., Donald-McGinn D.M., Saitta S.C., Harris S.E., Moss E., Wang P.P., Zackai E., Emanuel B.S., Simon T.J. Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome. American Journal of Psychiatry 2004, 161:1700-1702.
8. Bearden C.E., Jawad A.F., Lynch D.R., Monterossso J.R., Sokol S., Donald-McGinn D.M., Saitta S.C., Harris S.E., Moss E., Wang P.P., Zackai E., Emanuel B.S., Simon T.J. Effects of COMT genotype on behavioral symptomatology in the 22q11.2 deletion syndrome. Child Neuropsychology 2005, 11:109-117.
9. Bilder R.M., Volavka J., Czobor P., Malhotra A.K., Kennedy J.L., Ni X., Goldman R.S., Hoptman M.J., Sheitman B., Lindenmayer J.P., Citrome L., McEvoy J.P., Kunz M., Chakos M., Cooper T.B., Lieberman J.A. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biological Psychiatry 2002, 52:701-707.
10. Chen J., Lipska B.K., Halim N., Ma Q.D., Matsumoto M., Melhem S., Kolachana B.S., Hyde T.M., Herman M.M., Apud J., Egan M.F., Kleinman J.E., Weinberger D.R. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. American Journal of Human Genetics 2004, 75:807-821.
11. Cheuk D.K., Wong V. Meta-analysis of association between a catechol-O-methyltransferase gene polymorphism and attention deficit hyperactivity disorder. Behavior Genetics 2006, 36:651-659.
12. Cornblatt B.A., Risch N.J., Faris G., Friedman D., Erlenmeyer-Kimling L. The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatry Research 1988, 26:223-238.
13. Delis D.C., Kramer J.H., Kaplan E., Ober B.A. California Verbal Learning Test-Second Edition (CVLT-II) 1994, The Psychological Corporation, San Antonio, TX.
14. Diamond A., Briand L., Fossella J., Gehlbach L. Genetic and neurochemical modulation of prefrontal cognitive functions in children. American Journal of Psychiatry 2004, 161:125-132.
15. Drabant E.M., Hariri A.R., Meyer-Lindenberg A., Munoz K.E., Mattay V.S., Kolachana B.S., Egan M.F., Weinberger D.R. Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Archives of General Psychiatry 2006, 63:1396-1406.
16. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., Goldman D., Weinberger D.R. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:6917-6922.
17. Enoch M.A., Waheed J.F., Harris C.R., Albaugh B., Goldman D. COMT Val158Met and cognition: main effects and interaction with educational attainment. Genes Brain and Behavior 2009, 8:36-42.
18. Gadow K.D., Roohi J., DeVincent C.J., Kirsch S., Hatchwell E. Association of COMT (Val158Met) and BDNF (Val66Met) gene polymorphisms with anxiety, ADHD and tics in children with autism spectrum disorder. Journal of Autism and Developmental Disorders 2009, 39:1542-1551.
19. Gerdes M., Solot C., Wang P.P., Moss E., LaRossa D., Randall P., Goldmuntz E., Clark B.J., Driscoll D.A., Jawad A., Emanuel B.S., Donald-McGinn D.M., Batshaw M.L., Zackai E.H. Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion. American Journal of Medical Genetics 1999, 85:127-133.
20. Glaser B., Debbane M., Hinard C., Morris M.A., Dahoun S.P., Antonarakis S.E., Eliez S. No evidence for an effect of COMT Val158Met genotype on executive function in patients with 22q11 deletion syndrome. American Journal of Psychiatry 2006, 163:537-539.
21. Goldman-Rakic P.S., Muly E.C., Williams G.V. D(1) receptors in prefrontal cells and circuits. Brain Research Reviews 2000, 31:295-301.
22. Gothelf D., Eliez S., Thompson T., Hinard C., Penniman L., Feinstein C., Kwon H., Jin S., Jo B., Antonarakis S.E., Morris M.A., Reiss A.L. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome. Nature Neuroscience 2005, 8:1500-1502.
23. Gothelf D., Michaelovsky E., Frisch A., Zohar A.H., Presburger G., Burg M., viram-Goldring A., Frydman M., Yeshaya J., Shohat M., Korostishevsky M., Apter A., Weizman A. Association of the low-activity COMT 158Met allele with ADHD and OCD in subjects with velocardiofacial syndrome. International Journal of Neuropsychopharmacology 2006, 1-8.
24. Gothelf D., Feinstein C., Thompson T., Gu E., Penniman L., Van S.E., Kwon H., Eliez S., Reiss A.L. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. American Journal of Psychiatry 2007, 164:663-669.
25. Gothelf D., Schaer M., Eliez S. Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome. Developmental Disabilities Research Reviews 2008, 14:59-68.
26. Gresham F.M., Elliot S.N. Social Skills Rating System 1990, American Guidance Service, Inc., Circle Pines, MN.
27. Harris M.E. Wisconsin card sorting test: scoring program (Version 2.0) 1988, Psychological Assessment Resources, Odessa FL.
28. Hettema J.M., An S.S., Bukszar J., van den Oord E.J., Neale M.C., Kendler K.S., Chen X. Catechol-O-methyltransferase contributes to genetic susceptibility shared among anxiety spectrum phenotypes. Biological Psychiatry 2008, 64:302-310.
29. Houlihan L.M., Harris S.E., Luciano M., Gow A.J., Starr J.M., Visscher P.M., Deary I.J. Replication study of candidate genes for cognitive abilities: the Lothian Birth Cohort 1936. Genes Brain & Behavior 2009, 8:238-247.
30. Jolin E.M., Weller R.A., Jessani N.R., Zackai E.H., McDonald-McGinn D.M., Weller E.B. Affective disorders and other psychiatric diagnoses in children and adolescents with 22q11.2 Deletion Syndrome. Journal of Affective Disorders 2009, 119:177-180.
31. Joober R., Gauthier J., Lal S., Bloom D., Lalonde P., Rouleau G., Benkelfat C., Labelle A. Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Archives of General Psychiatry 2002, 59:662-663.
32. Kates W.R., Antshel K.M., Abdulsabur N., Colgan D., Funke B., Fremont W., Higgins A.M., Kucherlapati R., Shprintzen R.J. A gender-moderated effect of a functional COMT polymorphism on prefrontal brain morphology and function in velo-cardio-facial syndrome (22q11.2 deletion syndrome). American Journal of Medical Genetics B Neuropsychiatric Genetics 2006, 141B:274-280.
33. Kern R.S., Green M.F., Nuechterlein K.H., Deng B.H. NIMH-MATRICS survey on assessment of neurocognition in schizophrenia. Schizophrenia Research 2004, 72:11-19.
34. Kremer I., Pinto M., Murad I., Muhaheed M., Bannoura I., Muller D.J., Schulze T.G., Reshef A., Blanaru M., Gathas S., Goichman R., Rietschel M., Dobrusin M., Bachner-Melman R., Nemanov L., Belmaker R.H., Maier W., Ebstein R.P. Family-based and case-control study of catechol-O-methyltransferase in schizophrenia among Palestinian Arabs. American Journal of Medical Genetics B Neuropsychiatric Genetics 2003, 119:35-39.
35. Lachman H.M., Morrow B., Shprintzen R., Veit S., Parsia S.S., Faedda G., Goldberg R., Kucherlapati R., Papolos D.F. Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. American Journal of Medical Genetics 1996, 67:468-472.
36. Malhotra A.K., Kestler L.J., Mazzanti C., Bates J.A., Goldberg T., Goldman D. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. American Journal of Psychiatry 2002, 159:652-654.
37. Mattay V.S., Goldberg T.E., Fera F., Hariri A.R., Tessitore A., Egan M.F., Kolachana B., Callicott J.H., Weinberger D.R. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:6186-6191.
38. Michaelovsky E., Gothelf D., Korostishevsky M., Frisch A., Burg M., Carmel M., Steinberg T., Inbar D., Apter A., Weizman A. Association between a common haplotype in the COMT gene region and psychiatric disorders in individuals with 22q11.2DS. International Journal of Neuropsychopharmacology 2008, 11:351-363.
39. Moss E.M., Batshaw M.L., Solot C.B., Gerdes M., Donald-McGinn D.M., Driscoll D.A., Emanuel B.S., Zackai E.H., Wang P.P. Psychoeducational profile of the 22q11.2 microdeletion: A complex pattern. Journal of Pediatrics 1999, 134:193-198.
40. NIMH-CDISC Computerized Diagnostic Interview Schedule for Children 2004.
41. Nuechterlein K.H. MATRICS; consensus cognitive battery manual MATRICS Assessment MATRICS Assessment Inc LA 2006.
42. Shashi V., Keshavan M.S., Howard T.D., Berry M.N., Basehore M.J., Lewandowski E., Kwapil T.R. Cognitive correlates of a functional COMT polymorphism in children with 22q11.2 deletion syndrome. Clinical Genetics 2006, 69:234-238.
43. Shifman S., Bronstein M., Sternfeld M., Pisante-Shalom A., Lev-Lehman E., Weizman A., Reznik I., Spivak B., Grisaru N., Karp L., Schiffer R., Kotler M., Strous R.D., Swartz-Vanetik M., Knobler H.Y., Shinar E., Beckmann J.S., Yakir B., Risch N., Zak N.B., Darvasi A. A highly significant association between a COMT haplotype and schizophrenia. American Journal of Human Genetics 2002, 71:1296-1302.
44. Shprintzen R.J. Velo-cardio-facial syndrome: 30 Years of study. Developmental Disabilities Research Reviews 2008, 14:3-10.
45. Swillen A., Devriendt K., Legius E., Eyskens B., Dumoulin M., Gewillig M., Fryns J.P. Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with VCFS. Journal of Medical Genetics 1997, 34:453-458.
46. Takarae Y., Schmidt L., Tassone F., Simon T.J. Catechol-O-methyltransferase polymorphism modulates cognitive control in children with chromosome 22q11.2 deletion syndrome. Cognitive Affective & Behavioral Neuroscience 2009, 9:83-90.
47. van Amelsvoort T., Zinkstok J., Figee M., Daly E., Morris R., Owen M.J., Murphy K.C., De Haan L., Linszen D.H., Glaser B., Murphy D.G. Effects of a functional COMT polymorphism on brain anatomy and cognitive function in adults with velo-cardio-facial syndrome. Psychological Medicine 2008, 38:89-100.
48. Vorstman J.A., Turetsky B.I., Sijmens-Morcus M.E., de Sain M.G., Dorland B., Sprong M., Rappaport E.F., Beemer F.A., Emanuel B.S., Kahn R.S., van Engeland H., Kemner C. Proline affects brain function in 22q11DS children with the low activity COMT 158 allele. Neuropsychopharmacology 2009, 34:739-746.
49. Wechsler D. Intelligence Scale for Children-3rd Edition (WISC-III) 1999, The Psychological Corporation, San Antonio.
50. Wechsler D. Individual Achievement Test-II (WIAT-II) 2001, The Psychological Corporation, San Antonio, TX.
51. Wechsler D. Intelligence Scale for Children-4th Edition 2003, The Psychological Corporation, San Antonio, TX.
52. Woodin M., Wang P.P., Aleman D., Donald-McGinn D., Zackai E., Moss E. Neuropsychological profile of children and adolescents with the 22q11.2 microdeletion. Genetics in Medicine 2001, 3:34-39.